HuRPE cells

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHuRPE cells
Drug Alias Namehuman primary retinal pigment epithelial cells (EyeCure Therapeutics)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationRetinitis PigmentosaOptic Atrophy, Hereditary, Leber
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPending
Originator CompaniesEyecure Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEyecure Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsMacular DegenerationOptic Atrophy, Hereditary, Leber

Other Information

ATC CodeN/A
Related LinksN/A